The International AIDS Vaccine Initiative (IAVI) announced the appointment of Dr. Adel A.F. Mahmoud to its Board of Directors. Dr. Mahmoud is a professor at Princeton University, former President of Merck Vaccines and former Chairman of Medicine at Case Western Reserve University. He joins a “diverse group of 12 directors from ten countries with backgrounds in finance, vaccinology, international development, academia and HIV treatment and prevention that oversees IAVI’s progress and shapes its long-term strategy.” IAVI President & CEO Margaret McGlynn said, “We are very pleased to have Adel join IAVI’s Board of Directors. His experience in the private sector, especially the development and delivery of preventive vaccines, and his in-depth knowledge of immunology and infectious diseases combined with his passion for the development of an AIDS vaccine will prove invaluable to IAVI. I look forward to working closely with Adel again, and welcome his addition to our Board.”

http://www.businesswire.com/news/home/20120409005637/en/Leading-Global-Health-Expert-Dr.-Adel-A.F.